Regional brand break through the Road.doc

 PAGE \* MERGEFORMAT 7 Regional brand break through the Road The pharmaceutical industry by many policy restrictions, the same degree of intense competition intensified, the phenomenon of drug homogenization serious, forcing companies begun to focus on brand management, a number of OTC species in particular. Writer in the April 15 Yaojiao Hui Xian discovered at the scene, exhibitors and more species rich, but many still vigorously promote their businesses profitable varieties. This reflects a reality: do you still have to rely on the main varieties of the brand. Enterprises will focus on the fist varieties, so as to brand started to drive sales of series of varieties, it is the success of OTC Marketing From EMKT. laws. However, the Chinese market is so big, all uneven regional development, regional differences in large enterprises with limited resources, many brands have an advantage only in some areas, leaving these areas with almost no market opportunities. After accumulating over the years, many species, though already occupied certain market share, but because the old marketing model, enterprises lack of innovation initiatives, advertising forms a single, coupled with similar competing products divided eroded market share growth markedly slowed, and some even decline. Many enterprises are facing a second off the troubled species. In view of this situation, to seek a breakthrough new markets, expand market coverage, replication performance growth in mature markets is another way. Row of stone particles: Inheritance not forget to Innovation In the 59th China National Pharmaceuticals Fair site, we learned that ‘drug found in Nanjing, China Tong Ren Tang Xian Forum’, one of the organizers of Nanjing Tong Ren Tang Pharmaceutical Co., Ltd. with the Forum in its row of the main varieties of traditional Chinese medicine stone particles, Runing particles vigorously the brand rally. Advantage of the current row of stone particles in the market concentrated in th